New system for assessing the prognosis of refractory anemia patients

[1]  I. Jinnai,et al.  Refractory anemia with severe dysplasia: clinical significance of morphological features in refractory anemia , 1998, Leukemia.

[2]  C. Preudhomme,et al.  17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ. , 1998, Blood.

[3]  T. Intragumtornchai,et al.  Myelodysplastic syndromes in Thailand: a retrospective pathologic and clinical analysis of 117 cases. , 1997, Leukemia research.

[4]  T Hamblin,et al.  International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.

[5]  B. Bain.  The bone marrow aspirate of healthy subjects , 1996, British journal of haematology.

[6]  A. Ganser,et al.  Myelodysplastic syndromes: clinical features. , 1996, Seminars in hematology.

[7]  P. Morel,et al.  Cytogenetics of myelodysplastic syndromes. , 1996, Seminars in hematology.

[8]  K. Byth,et al.  The myelodysplastic syndromes: an analysis of prognostic factors in 226 cases from a single institution , 1995, British journal of haematology.

[9]  C. Preudhomme,et al.  Prognostic value of c-mpl expression in myelodysplastic syndromes. , 1995, Leukemia.

[10]  H. Mizoguchi,et al.  Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases. Anemia Study Group of the Ministry of Health and Welfare. , 1995, Leukemia research.

[11]  S. Asano,et al.  Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. , 1993, Leukemia.

[12]  A. Ganser,et al.  Clinical course of myelodysplastic syndromes. , 1992, Hematology/oncology clinics of North America.

[13]  C. Hadnagy,et al.  ACQUIRED DYSERYTHROPOIESIS IN LIVER DISEASE , 1991, British journal of haematology.

[14]  N. Gattermann,et al.  Two types of acquired idiopathic sideroblastic anaemia (AISA) , 1990, British journal of haematology.

[15]  M. Tomonaga,et al.  Diagnostic significance of detecting pseudo‐Pelger‐Huet anomalies and micro‐megakaryocytes in myelodysplastic syndrome , 1986, British journal of haematology.

[16]  D. Machin,et al.  Myelodysplastic syndromes: a scoring system with prognostic significance , 1985, British journal of haematology.

[17]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.

[18]  H. Koeffler.  Myelodysplastic syndromes. , 1996, Seminars in hematology.

[19]  R. Larson,et al.  Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome. , 1996, Leukemia.

[20]  J. Mukiibi,et al.  Myelodysplastic syndromes (MDS) in Central Africans. , 1994, Tropical and geographical medicine.

[21]  J. Bennett,et al.  Classification and morphologic features of the myelodysplastic syndromes. , 1992, Seminars in oncology.

[22]  D. Karcher,et al.  The bone marrow in human immunodeficiency virus (HIV)-related disease. Morphology and clinical correlation. , 1991, American journal of clinical pathology.

[23]  J. Bennett,et al.  Modifications in the classification of primary myelodysplastic syndromes: The addition of a scoring system , 1985, Hematological oncology.